Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy KalVista Pharmaceuticals (KALV) stocks in Canada
Learn how to easily invest in KalVista Pharmaceuticals stocks.
KalVista Pharmaceuticals is a biotechnology business based in the US. KalVista Pharmaceuticals stocks (KALV.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $23 – a decrease of 1.75% over the previous week. KalVista Pharmaceuticals employs 70 staff and has a trailing 12-month revenue of around $3.8 million.
How to buy shares in KalVista Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KALV – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in KalVista Pharmaceuticals?
- Has coronavirus impacted KalVista Pharmaceuticals shares?
- KalVista Pharmaceuticals shares summary
- Compare share dealing platforms
- Is KalVista Pharmaceuticals stock a buy or sell?
- KalVista Pharmaceuticals performance over time
- KalVista Pharmaceuticals's financials
- How volatile are KalVista Pharmaceuticals shares?
- Does KalVista Pharmaceuticals pay a dividend?
- Have KalVista Pharmaceuticals shares ever split?
- Other common questions
KalVista Pharmaceuticals stock price (NASDAQ:KALV)Use our graph to track the performance of KALV stocks over time.
KalVista Pharmaceuticals shares at a glance
|Latest market close||$11.77|
|52-week range||$11.65 - $45.00|
|50-day moving average||$14.61|
|200-day moving average||$20.33|
|Wall St. target price||$51.71|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.72|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy KalVista Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
KalVista Pharmaceuticals price performance over time
|1 week (2022-01-13)||-1.75%|
|1 month (2021-12-17)||-10.83%|
|3 months (2021-10-20)||-32.67%|
|6 months (2021-07-20)||-46.21%|
|1 year (2021-01-20)||-27.52%|
|2 years (2020-01-17)||-36.58%|
|3 years (2019-01-18)||16.71|
|5 years (2017-01-20)||61.23%|
KalVista Pharmaceuticals financials
|Revenue TTM||$3.8 million|
|Gross profit TTM||$-41,286,000|
|Return on assets TTM||-28.9%|
|Return on equity TTM||-41.55%|
|Market capitalisation||$306.9 million|
TTM: trailing 12 months
KalVista Pharmaceuticals share dividends
We're not expecting KalVista Pharmaceuticals to pay a dividend over the next 12 months.
Have KalVista Pharmaceuticals's shares ever split?
KalVista Pharmaceuticals's shares were split on a 1:14 basis on 21 November 2016. So if you had owned 14 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your KalVista Pharmaceuticals shares – just the quantity. However, indirectly, the new 1300% higher share price could have impacted the market appetite for KalVista Pharmaceuticals shares which in turn could have impacted KalVista Pharmaceuticals's share price.
KalVista Pharmaceuticals share price volatility
Over the last 12 months, KalVista Pharmaceuticals's shares have ranged in value from as little as $11.65 up to $45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while KalVista Pharmaceuticals's is 1.9417. This would suggest that KalVista Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
KalVista Pharmaceuticals overview
KalVista Pharmaceuticals, Inc. , a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; KVD900, which has completed Phase II clinical trial for an oral on-demand therapy for acute HAE attacks; and KVD824, an oral product candidate for the treatment of HAE. The company is headquartered in Cambridge, Massachusetts. .
Stocks similar to KalVista Pharmaceuticals
KalVista Pharmaceuticals in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Companies Like KalVista Pharmaceuticals (NASDAQ:KALV) Are In A Position To Invest In Growth
KalVista Pharmaceuticals Inc Shares Fall 0.1% Below Previous 52-Week Low - Market Mover
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.